Skip to main content
Premium Trial:

Request an Annual Quote

Cardiology Genomic Testing Alliance Formed by Five Companies

NEW YORK ─ Five genomics companies and laboratories announced on Tuesday an alliance to raise awareness and utilization of genomic testing in cardiology.

The CardioGenomic Testing Alliance comprises Illumina, Fulgent Genetics, Invitae, GeneDx, and PerkinElmer Genomics and intends to inform healthcare providers and other stakeholders of the value of genomic testing in cardiology to assure adherence to professional medical society guidelines, inform medical management and cascade testing, and improve clinical outcomes, CGTA said.

Genomic testing in cardiology can identify those at risk for specific cardiac conditions, such as arrhythmias, cardiomyopathies, and congenital heart malformations, but utilization and awareness of such testing remains low despite evidence and major professional society recommendations, CGTA added.

Working with key stakeholders, CGTA aims to identify logistical barriers to testing and develop educational resources to address these barriers for providers and the public.

According to CGTA's website, organizations fitting its criteria for membership include genomics companies with technologies that can identify genetic susceptibility to cardiac disease; laboratories that provide genetic testing for cardiovascular disorders; and digital health companies that provide services that aid in genetic testing for cardiovascular disorders.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.